Larvol Delta - A-Study-to-Evaluate-the-Safety-and-Efficacy-of-AVTX002-for-the-Treatment-of-Poorly-Controlled-NonEosinophilic-Asthma

quisovalimab (AVTX-002) - Kyowa Kirin, Sanofi, Avalo Therap

http://clinicaltrials.gov/ct2/show/NCT05288504

Aug 16, 2022

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next